BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Free Report) was the recipient of a significant decline in short interest in July. As of July 15th, there was short interest totalling 4,800 shares, a decline of 53.4% from the June 30th total of 10,300 shares. Based on an average daily trading volume, of 154,100 shares, the short-interest […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report published on Saturday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV stock opened at $1.39 on Friday. The company has a market cap of $2.60 million, a PE ratio of -0.39 and […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report released on Friday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance BiondVax Pharmaceuticals stock opened at $1.46 on Friday. The company has a 50 day moving average price of $1.58 and a 200 day […]
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Down 0.7 % Shares of BVXV opened at $1.38 on Thursday. BiondVax Pharmaceuticals has a 52 week low of $1.29 and a […]
StockNews.com initiated coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Trading Down 0.7 % Shares of BVXV opened at $1.38 on Thursday. The firm has a market cap of $2.58 million, a […]